{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:15:59Z","timestamp":1788196559099,"version":"build-2803163510"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cardioembolic stroke (CES) often results in poorer outcomes than other ischemic stroke subtypes. Recent years have seen a marked increase in the scientific output of researchers, highlighting the need for a comprehensive bibliometric analysis to clarify the developmental trends, key research hotspots, and primary contributors in this research field.<\/jats:p>\n                    <jats:p>To perform a bibliometric analysis of CES utilizing HistCite Pro, CiteSpace, and VOSviewer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data were sourced from the Web of Science Core Collection, encompassing publications from January 1, 2011, to January 29, 2024. Publication characteristics were analyzed using HistCite Pro and the Web of Science, whereas VOSviewer and CiteSpace facilitated keyword and collaborative network analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 5498 publications were identified, originating from 7916 institutions across 112 countries\/regions, published in 897 journals, and authored by 29,620 researchers. The annual number of publications surged from 2014 to 2022, with the United States and the\n                      <jats:italic toggle=\"yes\">Journal of Stroke &amp; Cerebrovascular Diseases<\/jats:italic>\n                      leading in contributions. The keyword network revealed 6 key clusters, emphasizing biomarkers, causes of CES, and randomized clinical trials evaluating direct oral anticoagulants for treating embolic stroke of undetermined source (ESUS), CES, and cryptogenic stroke. Recent hotspots included direct oral anticoagulants, ESUS, Mendelian randomization, instruments, and atrial cardiopathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Research on CES has progressed rapidly, and research development and collaboration frequently occur across countries, regions, and institutions. Further strengthening these partnerships may advance the field. The recent focus on ESUS, Mendelian randomization, and atrial cardiopathy highlights the need for refined etiological phenotyping and individualized secondary prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049247","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:00:39Z","timestamp":1781600439000},"page":"e49247","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A bibliometric analysis of cardioembolic stroke utilizing HistCite Pro, CiteSpace, and VOSviewer"],"prefix":"10.1097","volume":"105","author":[{"given":"Dandan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neurology, The People\u2019s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Zhenjiang, Jiangsu, China"},{"name":"Department of Neurology, Affiliated Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyong","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-3995","authenticated-orcid":false,"given":"Fuling","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260831","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2468-2667(21)00230-9","article-title":"Primary stroke prevention worldwide: translating evidence into action.","volume":"7","author":"Owolabi","year":"2022","journal-title":"Lancet Public Health"},{"key":"R2-20260831","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41582-023-00921-z","article-title":"Addressing disparities in the global epidemiology of stroke.","volume":"20","author":"Prust","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"R3-20260831","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ncl.2024.03.002","article-title":"Cardioembolic stroke.","volume":"42","author":"Yu","year":"2024","journal-title":"Neurol Clin"},{"key":"R4-20260831","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tcm.2021.12.001","article-title":"Atrial fibrillation and stroke: a review and new insights.","volume":"33","author":"Escudero-Mart\u00ednez","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"R5-20260831","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2022.01.024","article-title":"Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: a systematic review.","volume":"99","author":"Stalikas","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R6-20260831","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/heartjnl-2019-314898","article-title":"Stroke and thromboembolism prevention in atrial fibrillation.","volume":"106","author":"Jame","year":"2020","journal-title":"Heart"},{"key":"R7-20260831","doi-asserted-by":"crossref","first-page":"e211221199213","DOI":"10.2174\/1573403X18666211221145714","article-title":"Cryptogenic stroke and embolic stroke of undetermined source: risk factors and approaches for detection of atrial fibrillation.","volume":"18","author":"Rakhimova","year":"2022","journal-title":"Curr Cardiol Rev"},{"key":"R8-20260831","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41582-022-00663-4","article-title":"Review and update of the concept of embolic stroke of undetermined source.","volume":"18","author":"Diener","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"R9-20260831","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamacardio.2023.4115","article-title":"Mendelian randomization as a tool for cardiovascular research: a review.","volume":"9","author":"Levin","year":"2024","journal-title":"JAMA Cardiol"},{"key":"R10-20260831","doi-asserted-by":"crossref","first-page":"e10477","DOI":"10.2196\/10477","article-title":"Trends and visibility of \u201cdigital health\u201d as a keyword in articles by JMIR publications in the new millennium: bibliographic-bibliometric analysis.","volume":"21","author":"Ahmadvand","year":"2019","journal-title":"J Med Internet Res"},{"key":"R11-20260831","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1530\/EOR-21-0065","article-title":"Global research status of anterior cruciate ligament reconstruction: a bibliometric analysis.","volume":"7","author":"Zhou","year":"2022","journal-title":"EFORT Open Rev"},{"key":"R12-20260831","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.21037\/tcr-23-1769","article-title":"Microbiome in gynecologic malignancies: a bibliometric analysis from 2012 to 2022.","volume":"13","author":"Lin","year":"2024","journal-title":"Transl Cancer Res"},{"key":"R13-20260831","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s40001-023-01195-3","article-title":"Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.","volume":"28","author":"Liu","year":"2023","journal-title":"Eur J Med Res"},{"key":"R14-20260831","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/JS9.0000000000001022","article-title":"Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis.","volume":"110","author":"Zhang","year":"2024","journal-title":"Int J Surg"},{"key":"R15-20260831","doi-asserted-by":"crossref","first-page":"113932","DOI":"10.1016\/j.bios.2021.113932","article-title":"Frontier and hot topics in electrochemiluminescence sensing technology based on CiteSpace bibliometric analysis.","volume":"201","author":"Liu","year":"2022","journal-title":"Biosens Bioelectron"},{"key":"R16-20260831","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct.","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"key":"R17-20260831","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","article-title":"Embolic stroke of undetermined source: a systematic review and clinical update.","volume":"48","author":"Hart","year":"2017","journal-title":"Stroke"},{"key":"R18-20260831","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source.","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"key":"R19-20260831","doi-asserted-by":"crossref","first-page":"131873","DOI":"10.1016\/j.chemosphere.2021.131873","article-title":"Bibliometric analysis and recent trends on MXene research - a comprehensive review.","volume":"286","author":"Saravanan","year":"2022","journal-title":"Chemosphere"},{"key":"R20-20260831","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/jan.14757","article-title":"Research focus and thematic trends in magnet hospital research: a bibliometric analysis of the global publications.","volume":"77","author":"Yang","year":"2021","journal-title":"J Adv Nurs"},{"key":"R21-20260831","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jconrel.2022.03.031","article-title":"Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020.","volume":"345","author":"Peng","year":"2022","journal-title":"J Control Release"},{"key":"R22-20260831","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1097\/JS9.0000000000000492","article-title":"Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis.","volume":"109","author":"Jiang","year":"2023","journal-title":"Int J Surg"},{"key":"R23-20260831","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1474-4422(23)00277-6","article-title":"Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization-Lancet Neurology Commission.","volume":"22","author":"Feigin","year":"2023","journal-title":"Lancet Neurol"},{"key":"R24-20260831","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","article-title":"Epidemiology and modifiable risk factors for atrial fibrillation.","volume":"20","author":"Elliott","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"R25-20260831","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.3390\/ijms25115777","article-title":"Cardioembolic stroke: past advancements, current challenges, and future directions.","volume":"25","author":"Kato","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R26-20260831","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1111\/ene.15356","article-title":"Classification of patients with embolic stroke of undetermined source into cardioembolic and non-cardioembolic profile subgroups.","volume":"29","author":"Martin","year":"2022","journal-title":"Eur J Neurol"},{"key":"R27-20260831","first-page":"119","article-title":"Role of transcranial Doppler ultrasonography in detecting and excluding ischemic stroke in the emergency department: a prospective observational study.","volume":"62","author":"A\u011fa\u00e7kiran","year":"2025","journal-title":"Noro Psikiyatr Ars"},{"key":"R28-20260831","first-page":"448","article-title":"Update on biomarkers associated to cardioembolic stroke: a narrative review.","volume":"11","author":"Fonseca","year":"2021","journal-title":"Life (Basel)"},{"key":"R29-20260831","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1080\/00207454.2017.1408612","article-title":"Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: a comparative diagnostic meta-analysis.","volume":"128","author":"Bai","year":"2018","journal-title":"Int J Neurosci"},{"key":"R30-20260831","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/STROKEAHA.115.011392","article-title":"Procalcitonin and midregional proatrial natriuretic peptide as markers of ischemic stroke: the Northern Manhattan Study.","volume":"47","author":"Katan","year":"2016","journal-title":"Stroke"},{"key":"R31-20260831","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1212\/WNL.0000000000004922","article-title":"Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.","volume":"90","author":"De Marchis","year":"2018","journal-title":"Neurology"},{"key":"R32-20260831","doi-asserted-by":"crossref","first-page":"104528","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104528","article-title":"Troponin T predicts cardioembolic aetiology and clinical outcome in undetermined ischaemic stroke in hyperacute phase.","volume":"29","author":"Terce\u00f1o","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R33-20260831","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/STROKEAHA.117.019395","article-title":"Early elevated troponin levels after ischemic stroke suggests a cardioembolic source.","volume":"49","author":"Yaghi","year":"2018","journal-title":"Stroke"},{"key":"R34-20260831","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/STROKEAHA.120.029628","article-title":"High-sensitivity cardiac troponin T for risk stratification in patients with embolic stroke of undetermined source.","volume":"51","author":"Scheitz","year":"2020","journal-title":"Stroke"},{"key":"R35-20260831","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1007\/s00415-012-6532-4","article-title":"Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin.","volume":"259","author":"Santamarina","year":"2012","journal-title":"J Neurol"},{"key":"R36-20260831","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/jscd.2003.16","article-title":"C-reactive protein in ischemic stroke and its etiologic subtypes.","volume":"12","author":"Eikelboom","year":"2003","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R37-20260831","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1160\/TH08-06-0375","article-title":"Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke.","volume":"101","author":"Licata","year":"2009","journal-title":"Thromb Haemost"},{"key":"R38-20260831","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2009.06.019","article-title":"Plasma levels of inflammatory and thrombotic\/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site.","volume":"215","author":"Tuttolomondo","year":"2009","journal-title":"J Neuroimmunol"},{"key":"R39-20260831","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/STROKEAHA.107.505354","article-title":"Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.","volume":"39","author":"Montaner","year":"2008","journal-title":"Stroke"},{"key":"R40-20260831","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.08.013","article-title":"Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype.","volume":"21","author":"Hirano","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R41-20260831","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/jnnp.2010.230870","article-title":"Usefulness of measurement of fibrinogen, D-dimer, D-dimer\/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke.","volume":"82","author":"Alvarez-Perez","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R42-20260831","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajem.2018.05.010","article-title":"Contribution of routine cardiac biological markers to the etiological workup of ischemic stroke.","volume":"37","author":"Tomich","year":"2019","journal-title":"Am J Emerg Med"},{"key":"R43-20260831","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1001\/archinte.162.22.2589","article-title":"Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes.","volume":"162","author":"Ageno","year":"2002","journal-title":"Arch Intern Med"},{"key":"R44-20260831","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1076029611432744","article-title":"Increased plasma soluble thrombomodulin levels in cardioembolic stroke.","volume":"18","author":"Dharmasaroja","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"R45-20260831","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1161\/STROKEAHA.115.009989","article-title":"Electrocardiographic left atrial abnormality and risk of stroke: Northern Manhattan Study.","volume":"46","author":"Kamel","year":"2015","journal-title":"Stroke"},{"key":"R46-20260831","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.24482","article-title":"Electrocardiographic left atrial abnormality and stroke subtype in the Atherosclerosis Risk in Communities study.","volume":"78","author":"Kamel","year":"2015","journal-title":"Ann Neurol"},{"key":"R47-20260831","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1542-474X.2007.00133.x","article-title":"Interatrial block: a novel risk factor for embolic stroke?","volume":"12","author":"Ariyarajah","year":"2007","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"R48-20260831","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000206853","article-title":"Frequent premature atrial contractions in stroke of undetermined etiology.","volume":"61","author":"Todo","year":"2009","journal-title":"Eur Neurol"},{"key":"R49-20260831","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7461\/jcen.2013.15.3.131","article-title":"Relation between left atrial enlargement and stroke subtypes in acute ischemic stroke patients.","volume":"15","author":"Shin","year":"2013","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"R50-20260831","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/STROKEAHA.119.025384","article-title":"Left atrial volume index is associated with cardioembolic stroke and atrial fibrillation detection after embolic stroke of undetermined source.","volume":"50","author":"Jordan","year":"2019","journal-title":"Stroke"},{"key":"R51-20260831","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/acn3.50841","article-title":"Relationship between left atrial volume and ischemic stroke subtype.","volume":"6","author":"Kamel","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"R52-20260831","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1161\/STROKEAHA.114.005540","article-title":"Left atria strain is a surrogate marker for detection of atrial fibrillation in cryptogenic strokes.","volume":"45","author":"Pagola","year":"2014","journal-title":"Stroke"},{"key":"R53-20260831","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/STROKEAHA.117.019641","article-title":"Patients with undetermined stroke have increased atrial fibrosis: a cardiac magnetic resonance imaging study.","volume":"49","author":"Fonseca","year":"2018","journal-title":"Stroke"},{"key":"R54-20260831","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0197-2456(97)00012-3","article-title":"Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).","volume":"18","author":"Adams","year":"1997","journal-title":"Control Clin Trials"},{"key":"R55-20260831","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/hs1201.100209","article-title":"Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study.","volume":"32","author":"Kolominsky-Rabas","year":"2001","journal-title":"Stroke"},{"key":"R56-20260831","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"R57-20260831","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2217\/fca.15.22","article-title":"Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.","volume":"11","author":"Kamel","year":"2015","journal-title":"Future Cardiol"},{"key":"R58-20260831","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","article-title":"Atrial fibrillation and mechanisms of stroke: time for a new model.","volume":"47","author":"Kamel","year":"2016","journal-title":"Stroke"},{"key":"R59-20260831","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1747493019876543","article-title":"Atrial cardiopathy and stroke mortality in the general population.","volume":"15","author":"Ahmad","year":"2020","journal-title":"Int J Stroke"},{"key":"R60-20260831","doi-asserted-by":"crossref","first-page":"e21045","DOI":"10.1161\/JAHA.121.021045","article-title":"Secondary stroke prevention following embolic stroke of unknown source in the absence of documented atrial fibrillation: a clinical review.","volume":"10","author":"Kotadia","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R61-20260831","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1747493018799981","article-title":"The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods.","volume":"14","author":"Kamel","year":"2019","journal-title":"Int J Stroke"},{"key":"R62-20260831","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/CON.0000000000001217","article-title":"Diagnosis and management of cardioembolic stroke.","volume":"29","author":"Yaghi","year":"2023","journal-title":"Continuum (Minneap Minn)"},{"key":"R63-20260831","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCRESAHA.116.308447","article-title":"Cryptogenic stroke: research and practice.","volume":"120","author":"Yaghi","year":"2017","journal-title":"Circ Res"},{"key":"R64-20260831","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199605093341902","article-title":"Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke.","volume":"334","author":"Amarenco","year":"1996","journal-title":"N Engl J Med"},{"key":"R65-20260831","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1212\/WNL.46.6.1560","article-title":"Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population.","volume":"46","author":"Di Tullio","year":"1996","journal-title":"Neurology"},{"key":"R66-20260831","doi-asserted-by":"crossref","first-page":"e1003967","DOI":"10.1371\/journal.pmed.1003967","article-title":"Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: a Mendelian randomization study in multiple ancestries.","volume":"19","author":"Linden","year":"2022","journal-title":"PLoS Med"},{"key":"R67-20260831","doi-asserted-by":"crossref","first-page":"e30525","DOI":"10.1161\/JAHA.123.030525","article-title":"Association between prekallikrein and stroke: a Mendelian randomization study.","volume":"12","author":"Wang","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"R68-20260831","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1161\/STROKEAHA.118.022701","article-title":"Iron status and risk of stroke.","volume":"49","author":"Gill","year":"2018","journal-title":"Stroke"},{"key":"R69-20260831","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.118.035905","article-title":"Genetically determined levels of circulating cytokines and risk of stroke.","volume":"139","author":"Georgakis","year":"2019","journal-title":"Circulation"},{"key":"R70-20260831","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.119.040180","article-title":"Novel drug targets for ischemic stroke identified through Mendelian randomization analysis of the blood proteome.","volume":"140","author":"Chong","year":"2019","journal-title":"Circulation"},{"key":"R71-20260831","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R72-20260831","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.puhe.2016.12.033","article-title":"\u2018Mendelian randomization\u2019: an approach for exploring causal relations in epidemiology.","volume":"145","author":"Gupta","year":"2017","journal-title":"Public Health"},{"key":"R73-20260831","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ene.14172","article-title":"Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.","volume":"27","author":"Martinez-Majander","year":"2020","journal-title":"Eur J Neurol"},{"key":"R74-20260831","doi-asserted-by":"crossref","first-page":"104936","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104936","article-title":"Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: recurrent stroke risk and response to antithrombotic therapy.","volume":"29","author":"Ameriso","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R75-20260831","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/17474930211058012","article-title":"Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.","volume":"17","author":"Sharma","year":"2022","journal-title":"Int J Stroke"},{"key":"R76-20260831","first-page":"a2300235","article-title":"Apixaban versus aspirin for embolic stroke of undetermined source.","volume":"3","author":"Geisler","year":"2024","journal-title":"NEJM Evid"},{"key":"R77-20260831","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s40001-023-01406-x","article-title":"Association of tirofiban treatment with outcomes following endovascular therapy in cardioembolic stroke: insights from the RESCUE BT randomized trial.","volume":"28","author":"Rong","year":"2023","journal-title":"Eur J Med Res"},{"key":"R78-20260831","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2023.27188","article-title":"Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial.","volume":"331","author":"Kamel","year":"2024","journal-title":"JAMA"},{"key":"R79-20260831","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.2009.1307","article-title":"Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals.","volume":"302","author":"Kulkarni","year":"2009","journal-title":"JAMA"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:00:40Z","timestamp":1788195640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":79,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049247","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"2024-11-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}